Vanguard Capital Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Hold |
560
| – | – | 0.25% | 86 |
|
|
2025
Q1 | $271K | Sell |
560
-5
| -0.9% | -$2.42K | 0.33% | 70 |
|
|
2024
Q4 | $228K | Sell |
565
-90
| -14% | -$36.2K | 0.25% | 86 |
|
|
2024
Q3 | $305K | Sell |
655
-185
| -22% | -$86K | 0.32% | 69 |
|
|
2024
Q2 | $394K | Hold |
840
| – | – | 0.27% | 80 |
|
|
2024
Q1 | $351K | Buy |
840
+10
| +1% | +$4.18K | 0.25% | 82 |
|
|
2023
Q4 | $338K | Sell |
830
-240
| -22% | -$97.7K | 0.27% | 80 |
|
|
2023
Q3 | $372K | Buy |
1,070
+190
| +22% | +$66.1K | 0.34% | 69 |
|
|
2023
Q2 | $310K | Hold |
880
| – | – | 0.28% | 76 |
|
|
2023
Q1 | $277K | Hold |
880
| – | – | 0.28% | 81 |
|
|
2022
Q4 | $254K | Buy |
880
+80
| +10% | +$23.1K | 0.29% | 83 |
|
|
2022
Q3 | $232K | Buy |
+800
| New | +$232K | 0.28% | 81 |
|